These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 17291214

  • 41. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 42. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 43. Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder.
    Campisi P, Allen UD, Ngan BY, Hawkes M, Forte V.
    Otolaryngol Head Neck Surg; 2007 Aug; 137(2):296-300. PubMed ID: 17666259
    [Abstract] [Full Text] [Related]

  • 44. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 45. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 46. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
    Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG.
    Pediatr Transplant; 2008 Jun; 12(4):464-8. PubMed ID: 18466434
    [Abstract] [Full Text] [Related]

  • 47. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
    Lee TC, Goss JA, Rooney CM, Heslop HE, Barshes NR, Caldwell YM, Gee AP, Scott JD, Savoldo B.
    Clin Transplant; 2006 Jun; 20(6):689-94. PubMed ID: 17100717
    [Abstract] [Full Text] [Related]

  • 48. Posttransplant lymphoproliferative diseases.
    Gross TG, Savoldo B, Punnett A.
    Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
    [Abstract] [Full Text] [Related]

  • 49. Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
    Choquet S, Oertel S, LeBlond V, Riess H, Varoqueaux N, Dörken B, Trappe R.
    Ann Hematol; 2007 Aug; 86(8):599-607. PubMed ID: 17522862
    [Abstract] [Full Text] [Related]

  • 50. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Aug; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 51. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice.
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [Abstract] [Full Text] [Related]

  • 52. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN, Douglas LP, Andreadis C, Arnoldi S, Svoboda J, Kotloff RM, Hadjiliadis D, Sager JS, Woo YJ, Pochettino A, Schuster SJ, Stadtmauer EA, Tsai DE.
    J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
    [Abstract] [Full Text] [Related]

  • 53. [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
    Gómez E, Melón S, Fresno MF, Tricas L, Navascués R, de Oña M, Herreros M, Alvarez Grande J.
    Nefrologia; 2002 Aug; 22(6):574-81. PubMed ID: 12516292
    [Abstract] [Full Text] [Related]

  • 54. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 55. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
    Lee JJ, Lam MS, Rosenberg A.
    Ann Pharmacother; 2007 Oct; 41(10):1648-59. PubMed ID: 17848421
    [Abstract] [Full Text] [Related]

  • 56. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
    Garceau P, Couture C, Cantin B, Bernier V, Sénéchal M.
    J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
    [Abstract] [Full Text] [Related]

  • 57. Post-transplant lymphoproliferative disorder.
    Basgoz N, Preiksaitis JK.
    Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
    [Abstract] [Full Text] [Related]

  • 58. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
    Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS.
    Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
    [Abstract] [Full Text] [Related]

  • 59. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.
    Ahmad I, Cau NV, Kwan J, Maaroufi Y, Meuleman N, Aoun M, Lewalle P, Martiat P, Crokaert F, Bron D.
    Transplantation; 2009 Apr 27; 87(8):1240-5. PubMed ID: 19384173
    [Abstract] [Full Text] [Related]

  • 60. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.
    San-Juan R, Manuel O, Hirsch HH, Fernández-Ruiz M, López-Medrano F, Comoli P, Caillard S, Grossi P, Aguado JM, ESGICH PTLD Survey Study Group,, European Study Group of Infections in Compromised Hosts (ESGICH) from the European Society of Microbiology and Infectious Diseases (ESCMID).
    Clin Microbiol Infect; 2015 Jun 27; 21(6):604.e1-9. PubMed ID: 25686696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.